Pregabalin and Cachexia - a phase IV clinical study of FDA data

Summary:

Cachexia is reported as a side effect among people who take Pregabalin (pregabalin), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Torsemide, and have Parkinson's disease.

The phase IV clinical study analyzes which people have Cachexia when taking Pregabalin. It is created by eHealthMe based on reports of 73,056 people who have side effects when taking Pregabalin from the FDA, and is updated regularly.

What is Pregabalin?

Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,069 Pregabalin users. Check the latest studies of Pregabalin.

What is Cachexia?

Cachexia (loss of weight) is found to be associated with 659 drugs and 1,205 conditions by eHealthMe. Check the latest studies of Cachexia.

On Jul, 23, 2026

73,056 people reported to have side effects when taking Pregabalin.
Among them, 36 people (0.05%) have Cachexia.

Among these 36 people:

How long have people been on Pregabalin when they have Cachexia? *

What is the gender of people who have Cachexia when taking Pregabalin? *

female: 11.76 %
male: 88.24 %

What is the age of people who have Cachexia when taking Pregabalin? *

What are other drugs people take besides Pregabalin? *

What are other side effects people have besides Cachexia? *

General Physical Health Deterioration (weak health status): 26 people, 72.22%
Dehydration (dryness resulting from the removal of water): 25 people, 69.44%
Nausea And Vomiting: 25 people, 69.44%
Fatigue (feeling of tiredness): 25 people, 69.44%
Nausea (feeling of having an urge to vomit): 24 people, 66.67%
Anaemia (lack of blood): 24 people, 66.67%
Arrhythmias (irregular heartbeat): 23 people, 63.89%
Hyperglycemia (high blood sugar): 22 people, 61.11%
Tenderness (pain or discomfort when an affected area is touched): 22 people, 61.11%
Haematochezia (passage of stools containing blood): 22 people, 61.11%

What are the existing conditions these people have? *

Parkinson's Disease: 4 people, 11.11%
Metastases To Bone (cancer spreads to bone): 3 people, 8.33%
Tumor: 2 people, 5.56%
Hereditary Neuropathic Amyloidosis (hereditary- diseases resulting from abnormal deposition of certain proteins (amyloid) in various bodily areas by problems with signals from the nerves): 2 people, 5.56%
Renal Cell Carcinoma (a kidney cancer): 2 people, 5.56%
Urinary Tract Infection: 1 person, 2.78%
Constipation: 1 person, 2.78%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 1 person, 2.78%
Hallucinations (sensations that appear real but are created by your mind): 1 person, 2.78%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Pregabalin and have Cachexia?

- Check whether Cachexia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pregabalin:

Pregabalin (74,069 reports)

Cachexia treatments and more:

Cachexia (7,763 reports)

Browse all side effects of Pregabalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cachexia:

Cachexia (659 drugs)

Browse all the conditions that are associated with Cachexia:

Cachexia (1,205 conditions)

Related publications that referenced our studies

de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .
de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on pregabalin (the active ingredients of Pregabalin) and Pregabalin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.